Home › Funds › DAFNA Capital Management LLC › RCUS
DAFNA Capital Management LLC position in RCUS
ARCUS BIOSCIENCES INC · Health Care
DAFNA Capital Management LLC reported holding 441,829 shares of RCUS (ARCUS BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$13.6M, representing 2.60% of its reported portfolio and ranking #11 among its reported holdings. DAFNA Capital Management LLC has disclosed RCUS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DAFNA Capital Management LLC's RCUS position evolved
DAFNA Capital Management LLC first disclosed a stake in RCUS in Q3 2023 at 222,717 shares (US$4.0M). The position peaked in Q2 2026 at 441,829 shares, worth US$13.6M. Across 12 filings, DAFNA Capital Management LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 441,829 shares valued at US$13.6M. Notable position changes include a 146% increase in Q1 2025 (shares rose 4% over the following quarter), a 31% trim in Q4 2025 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 222.72K | $4.00M | New |
| Q4 2023 | 232.72K | $4.44M | Add |
| Q1 2024 | 231.72K | $4.37M | Hold |
| Q2 2024 | 253.22K | $3.86M | Add |
| Q3 2024 | 256.72K | $3.93M | Add |
| Q4 2024 | 254.22K | $3.79M | Reduce |
| Q1 2025 | 625.13K | $4.91M | Add |
| Q2 2025 | 627.63K | $5.11M | Hold |
| Q3 2025 | 627.63K | $8.54M | Hold |
| Q4 2025 | 431.33K | $10.28M | Reduce |
| Q1 2026 | 443.83K | $9.59M | Add |
| Q2 2026 | 441.83K | $13.62M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RCUS and 13F data
RCUS (ARCUS BIOSCIENCES INC) is a Health Care company. 46 other funds we track also report a position in RCUS — the largest reported positions include GILEAD SCIENCES, INC. (US$968.8M), MONTANOVA CAPITAL, LLC (US$147.3M), Siren, L.L.C. (US$74.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RCUS
- GILEAD SCIENCES, INC. 31.42M sh · $968.83M · Q2 2026
- MONTANOVA CAPITAL, LLC 4.78M sh · $147.26M · Q2 2026
- Siren, L.L.C. 2.42M sh · $74.62M · Q2 2026
- SAMLYN CAPITAL, LLC 1.55M sh · $47.70M · Q2 2026
- Soleus Capital Management, L.P. 1.17M sh · $36.03M · Q2 2026
- Sofinnova Investments, Inc. 945.69K sh · $29.16M · Q2 2026
- Parkman Healthcare Partners LLC 919.27K sh · $28.34M · Q2 2026
- BAKER BROS. ADVISORS LP 844.82K sh · $26.05M · Q2 2026
- Logos Global Management LP 650.00K sh · $20.04M · Q2 2026
- Ikarian Capital, LLC 504.56K sh · $15.56M · Q2 2026
- Decheng Capital LLC 464.78K sh · $14.33M · Q2 2026
- Patient Square Capital LP 355.80K sh · $10.97M · Q2 2026
More on DAFNA Capital Management LLC
FAQ
How long has DAFNA Capital Management LLC held RCUS?
DAFNA Capital Management LLC has disclosed RCUS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is DAFNA Capital Management LLC's current position in RCUS?
As of Q2 2026, DAFNA Capital Management LLC holds 441.83K shares of RCUS (ARCUS BIOSCIENCES INC), valued at $13.62M, representing 2.60% of its reported portfolio and ranking #11.
Has DAFNA Capital Management LLC been buying or selling RCUS?
In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC held unchanged its position in RCUS. The position peaked in Q2 2026 at 441.83K shares.
Which other funds hold RCUS?
Other major institutional holders of RCUS include GILEAD SCIENCES, INC., MONTANOVA CAPITAL, LLC, Siren, L.L.C., among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.